TLSI
TriSalus Life Sciences, Inc.
NASDAQ · USHealthcareMedical - Devices
$4.31+0.47%
Price as of Jul 20, 2026
TLSI profitability
TriSalus Life Sciences, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 85.1%
- EBITDA margin
- -46.7%
- EBIT margin
- -62.4%
- Net margin
- -60.9%
- Free cash flow margin
- -45.2%
Returns
- Return on equity
- -213.3%
- Return on assets
- -38.5%
- Return on invested capital
- -59.3%
- Asset turnover
- 0.84x
Cash efficiency
- Cash from operations
- -$20.0M
- Cash per share
- $0.92
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.